From Departments of Nephrology (R.H.G.O.E., T.C.v.d.H., N.D.v.N., H.P.-S., L.V.) and Vascular Medicine (B.J.H.v.d.B.), Academic Medical Center, Amsterdam, The Netherlands.
Circulation. 2017 Sep 5;136(10):917-926. doi: 10.1161/CIRCULATIONAHA.117.029028. Epub 2017 Jun 27.
A decrease in sodium intake has been shown to lower blood pressure, but data from cohort studies on the association with cardiovascular and renal outcomes are inconsistent. In these studies, sodium intake was often estimated with a single baseline measurement, which may be inaccurate considering day-to-day changes in sodium intake and sodium excretion. We compared the effects of single versus repetitive follow-up 24-hour urine samples on the relation between sodium intake and long-term cardiorenal outcomes.
We selected adult subjects with an estimated glomerular filtration rate >60 mL/min/1.73m, an outpatient 24-hour urine sample between 1998 and 1999, and at least 1 collection during a 17-year follow-up. Sodium intake was estimated with a single baseline collection and the average of samples collected during a 1-, 5-, and 15-year follow-up. We used Cox regression analysis and the landmark approach to investigate the relation between sodium intake and cardiovascular (cardiovascular events or mortality) and renal (end-stage renal disease: dialysis, transplantation, and/or >60% estimated glomerular filtration rate decline, or mortality) outcomes.
We included 574 subjects with 9776 twenty-four-hour urine samples. Average age was 47 years, and 46% were male. Median follow-up was 16.2 years. Average 24-hour sodium excretion, ranging from 3.8 to 3.9 g (165-170 mmol), was equal among all methods (=0.88). However, relative to a single baseline measurement, 50% of the subjects had a >0.8-g (>34-mmol) difference in sodium intake with long-term estimations. As a result, 45%, 49%, and 50% of all subjects switched between tertiles of sodium intake when the 1-, 5-, or 15-year average was used, respectively. Consequently, hazard ratios for cardiorenal outcome changed up to 85% with the use of sodium intake estimations from short-term (1-year) and long-term (5-year) follow-up instead of baseline estimations.
Relative to a single baseline 24-hour sodium measurement, the use of subsequent 24-hour urine samples resulted in different estimations of an individual's sodium intake, whereas population averages remained similar. This finding had significant consequences for the association between sodium intake and long-term cardiovascular and renal outcomes.
已有研究表明,减少钠的摄入量可降低血压,但队列研究中关于钠的摄入量与心血管和肾脏结局的相关性的数据并不一致。在这些研究中,通常用单一的基线测量来估计钠的摄入量,而考虑到钠摄入量和钠排泄的日常变化,这种方法可能并不准确。我们比较了单次和重复随访 24 小时尿液样本对钠摄入量与长期心肾结局之间关系的影响。
我们选择肾小球滤过率>60ml/min/1.73m 的成年受试者,在 1998 年至 1999 年期间采集门诊 24 小时尿液样本,并在 17 年的随访期间至少采集一次样本。用单次基线采集和 1 年、5 年和 15 年随访期间采集的样本平均值来估计钠的摄入量。我们使用 Cox 回归分析和 landmark 方法来研究钠摄入量与心血管(心血管事件或死亡率)和肾脏(终末期肾病:透析、移植和/或>60%肾小球滤过率下降,或死亡率)结局之间的关系。
我们纳入了 574 名受试者,共 9776 份 24 小时尿液样本。平均年龄为 47 岁,46%为男性。中位随访时间为 16.2 年。平均 24 小时钠排泄量为 3.8 至 3.9g(165-170mmol),所有方法之间相等(=0.88)。然而,与单次基线测量相比,50%的受试者在长期估计中钠摄入量的差异>0.8g(>34mmol)。因此,当使用 1 年、5 年或 15 年的平均值时,所有受试者中分别有 45%、49%和 50%的人在钠摄入量的三分位之间转换。因此,与基线估计相比,使用短期(1 年)和长期(5 年)随访的钠摄入量估计值,心肾结局的风险比变化高达 85%。
与单次基线 24 小时钠测量相比,后续 24 小时尿液样本的使用会导致个体钠摄入量的不同估计,而人群平均值则保持相似。这一发现对钠摄入量与长期心血管和肾脏结局之间的关系有重要影响。